Exicure receives Nasdaq extension: what it means for Exicure stock
Published on 10/07/2026 at 06:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSExicure (ISIN US30205M3097) received a Nasdaq extension tied to its USD 2.50 million stockholders' equity requirement through December 2, 2026, according to GlobeNewswire on September 16, 2026. The decision gives Exicure additional time to demonstrate compliance with Nasdaq Listing Rule 5550(b)(1), but it does not confirm that compliance has been restored.
The December 2 compliance test
The extension followed a Nasdaq notice dated June 5, 2026, when Exicure failed to meet the minimum stockholders' equity standard. The company must complete its compliance initiatives and publicly demonstrate at least USD 2.50 million in stockholders' equity by December 2, 2026, while Nasdaq continues monitoring its status through the next periodic report.
The listing risk is material because Nasdaq said Exicure also failed alternative continued-listing standards based on the market value of listed securities or net income from continuing operations. If the terms are not met, Nasdaq may issue a written delisting determination, with an appeal to a Nasdaq Hearings Panel available to the company.
Q2 numbers show the pressure
Exicure's second-quarter 2026 filing, dated August 14, 2026, showed USD 0 in revenue and diluted earnings per share of USD -0.18. Operating cash flow was negative USD 887,000 and cash stood at USD 1.7 million for the quarter, according to ToAlpha.
The latest annual comparison reinforces the financing challenge. Revenue was USD 0 in fiscal 2025 versus USD 0.5 million in fiscal 2024, while net loss narrowed to USD 4.9 million from USD 9.7 million, according to StockTitan.
Market reference remains dated
The last Lang & Schwarz prior close was EUR 0.95 on October 5, 2026. The primary Nasdaq quote was USD 1.08 on October 6, 2026 at 4:00 p.m. EDT, against a 52-week range of USD 1.05 to USD 9.48; the market capitalization was USD 6.9 million on that date. The compliance deadline, cash position and equity threshold leave financing and listing status as the central measurable issues for Exicure stock.
The further course of trading is shown by the continuously updated real-time quote of Exicure stock.
Exicure stock facts
- Company: Exicure, Inc.
- ISIN: US30205M3097
- Ticker: XCUR
- Primary exchange: Nasdaq
- Prior close Lang & Schwarz (October 5, 2026): EUR 0.95
- Market capitalization: USD 6.9 million as of October 6, 2026
- 52-week range: USD 1.05-USD 9.48 as of October 6, 2026
- Sector / Industry: Healthcare / Biotechnology
